BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 29316404)

  • 1. The CXCL12-CXCR4 axis promotes migration, invasiveness, and EMT in human papillary thyroid carcinoma B-CPAP cells via NF-κB signaling.
    Lin Y; Ma Q; Li L; Wang H
    Biochem Cell Biol; 2018 Oct; 96(5):619-626. PubMed ID: 29316404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated CXCL5-CXCR2 axis promotes the migration, invasion and EMT of papillary thyroid carcinoma cells via modulation of β-catenin pathway.
    Cui D; Zhao Y; Xu J
    Biochimie; 2018 May; 148():1-11. PubMed ID: 29471001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twist1 regulates the epithelial-mesenchymal transition via the NF-κB pathway in papillary thyroid carcinoma.
    Lv N; Shan Z; Gao Y; Guan H; Fan C; Wang H; Teng W
    Endocrine; 2016 Mar; 51(3):469-77. PubMed ID: 26289126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and function of CXCL12/CXCR4/CXCR7 in thyroid cancer.
    Zhu X; Bai Q; Lu Y; Lu Y; Zhu L; Zhou X; Wu L
    Int J Oncol; 2016 Jun; 48(6):2321-9. PubMed ID: 27082011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The expression and significance of trefoil factor 3 and SDF-1/CXCR4 biological axis in papillary thyroid carcinoma].
    Xue G; Huang J; Zhang H; Zhang W; Wu J; Shang X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jan; 28(2):108-12. PubMed ID: 24738314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artemin regulates CXCR4 expression to induce migration and invasion in pancreatic cancer cells through activation of NF-κB signaling.
    Wang J; Wang H; Cai J; Du S; Xin B; Wei W; Zhang T; Shen X
    Exp Cell Res; 2018 Apr; 365(1):12-23. PubMed ID: 29453972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LPS-induced CXCR4-dependent migratory properties and a mesenchymal-like phenotype of colorectal cancer cells.
    Liu WT; Jing YY; Yan F; Han ZP; Lai FB; Zeng JX; Yu GF; Fan QM; Li R; Zhao QD; Wu MC; Wei LX
    Cell Adh Migr; 2017 Jan; 11(1):13-23. PubMed ID: 26745593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
    Qiao N; Wang L; Wang T; Li H
    Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional expression of the CXCR4 chemokine receptor is induced by RET/PTC oncogenes and is a common event in human papillary thyroid carcinomas.
    Castellone MD; Guarino V; De Falco V; Carlomagno F; Basolo F; Faviana P; Kruhoffer M; Orntoft T; Russell JP; Rothstein JL; Fusco A; Santoro M; Melillo RM
    Oncogene; 2004 Aug; 23(35):5958-67. PubMed ID: 15184868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMD3100 inhibits epithelial-mesenchymal transition, cell invasion, and metastasis in the liver and the lung through blocking the SDF-1α/CXCR4 signaling pathway in prostate cancer.
    Zhu WB; Zhao ZF; Zhou X
    J Cell Physiol; 2019 Jul; 234(7):11746-11759. PubMed ID: 30537000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCR7 is not obligatory for CXCL12-CXCR4-induced epithelial-mesenchymal transition in human ovarian cancer.
    Zheng N; Liu W; Chen J; Li B; Liu J; Wang J; Gao Y; Shao J; Jia L
    Mol Carcinog; 2019 Jan; 58(1):144-155. PubMed ID: 30259564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF-κB signaling pathway confers neuroblastoma cells migration and invasion ability via the regulation of CXCR4.
    Zhi Y; Duan Y; Zhou X; Yin X; Guan G; Zhang H; Dong Q; Yang K
    Med Sci Monit; 2014 Dec; 20():2746-52. PubMed ID: 25527973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCL12/CXCR4 axis induced miR-125b promotes invasion and confers 5-fluorouracil resistance through enhancing autophagy in colorectal cancer.
    Yu X; Shi W; Zhang Y; Wang X; Sun S; Song Z; Liu M; Zeng Q; Cui S; Qu X
    Sci Rep; 2017 Feb; 7():42226. PubMed ID: 28176874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell surface nucleolin is crucial in the activation of the CXCL12/CXCR4 signaling pathway.
    Yang X; Xu Z; Li D; Cheng S; Fan K; Li C; Li A; Zhang J; Feng M
    Tumour Biol; 2014 Jan; 35(1):333-8. PubMed ID: 23918302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCR4/CXCR7/CXCL12 axis promotes an invasive phenotype in medullary thyroid carcinoma.
    Werner TA; Forster CM; Dizdar L; Verde PE; Raba K; Schott M; Knoefel WT; Krieg A
    Br J Cancer; 2017 Dec; 117(12):1837-1845. PubMed ID: 29112684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chaperone-mediated Autophagy Governs Progression of Papillary Thyroid Carcinoma via PPARγ-SDF1/CXCR4 Signaling.
    Zhou H; Xie X; Chen Y; Lin Y; Cai Z; Ding L; Wu Y; Peng Y; Tang S; Xu H
    J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32556197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXC chemokine receptor 4 expression and function in human anaplastic thyroid cancer cells.
    Hwang JH; Hwang JH; Chung HK; Kim DW; Hwang ES; Suh JM; Kim H; You KH; Kwon OY; Ro HK; Jo DY; Shong M
    J Clin Endocrinol Metab; 2003 Jan; 88(1):408-16. PubMed ID: 12519884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRAFV600E and RET/PTC Promote Proliferation and Migration of Papillary Thyroid Carcinoma Cells In Vitro by Regulating Nuclear Factor-κB.
    Zhou D; Li Z; Bai X
    Med Sci Monit; 2017 Nov; 23():5321-5329. PubMed ID: 29117154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of Serine Proteinase Inhibitor Clade B Member 3 (SERPINB3) Expression by Stromal Cell-Derived Factor (SDF-1)/CXCR4/Nuclear Factor kappa B (NF-κB) Promotes Migration and Invasion of Gastric Cancer Cells.
    Gong J; Song Y; Xu L; Che X; Hou K; Guo T; Cheng Y; Liu Y; Qu X
    Med Sci Monit; 2020 Oct; 26():e927411. PubMed ID: 33110054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCR4 expression in papillary thyroid carcinoma: induction by nitric oxide and correlation with lymph node metastasis.
    Yasuoka H; Kodama R; Hirokawa M; Takamura Y; Miyauchi A; Sanke T; Nakamura Y
    BMC Cancer; 2008 Sep; 8():274. PubMed ID: 18826577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.